IRS Floats Updates To Fee Paid By Brand Drugmakers
By Anna Scott Farrell · January 2, 2026, 1:29 PM EST
The Internal Revenue Service floated updates to regulations governing how branded prescription drug manufacturers or importers should calculate an annual fee established by the Affordable Care Act, a move the agency...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login